ESR1 and breast carcinoma: Based on the presence of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2, also known as Neu/ErbB-2), receptor status along with tumor grading has categorized breast cancer into several conceptual molecular classes [7,8].